{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:42:30Z","timestamp":1775724150076,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA039139"],"award-info":[{"award-number":["R01DA039139"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA013429"],"award-info":[{"award-number":["P30DA013429"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.neuropharm.2016.04.014","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T20:55:18Z","timestamp":1460580918000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator"],"prefix":"10.1016","volume":"108","author":[{"given":"Ryan A.","family":"Gregg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callum","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil U.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Nucero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen B.","family":"Reitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.04.014_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","article-title":"The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats","volume":"71","author":"Aarde","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib2","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00213-014-3819-4","article-title":"Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.forsciint.2012.08.040","article-title":"Synthesis and GC\u2013MS analysis of a series of homologs and regioisomers of 3,4-methylenedioxypyrovalerone (MDPV)","volume":"223","author":"Abiedalla","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2012.03.045","article-title":"Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm","volume":"1456","author":"Abulseoud","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib49","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1111\/bph.13330","article-title":"Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat","volume":"172","author":"Barr","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","article-title":"Abuse-related and abuse limiting effects of methcathinone and the synthetic cathinone \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats","volume":"231","author":"Bonano","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0006-8993(94)01420-M","article-title":"Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference","volume":"673","author":"Cervo","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib9","series-title":"All Controlled Substances in Alphabetical Order [Report]","author":"DEA Office of Diversion Control","year":"2015"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib10","series-title":"Chemicals Used in \u201cBath Salts\u201d Now under Federal Control and Regulation [Press Statement]","author":"DEA Public Affairs","year":"2011"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2014.04.017","article-title":"A\u00a03-year review of new psychoactive substances in casework","volume":"243","author":"Elliott","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","article-title":"In\u00a0vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity","volume":"38","author":"Fantegrossi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuroscience.2012.02.049","article-title":"Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell","volume":"210","author":"Fischer-Smith","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.drugalcdep.2013.06.014","article-title":"Mephedrone (4-methylmethcathinone), a principal component in psychoactive bath salts, produces behavioral sensitization in rats","volume":"133","author":"Gregg","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/FBP.0000000000000006","article-title":"Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats","volume":"24","author":"Gregg","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/bph.12951","article-title":"Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioral and neurochemical effects in rats","volume":"172","author":"Gregg","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1046\/j.1471-4159.1998.70041497.x","article-title":"Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area","volume":"70","author":"Kalivas","year":"1998","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2016.04.014_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamate transmission in addiction","volume":"56","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/bcpt.12253","article-title":"Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice","volume":"115","author":"Karlsson","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pbb.2015.07.013","article-title":"Sex differences in 3,4-methylenedioxypyrovalerone (MDPV)-induced taste avoidance and place preferences","volume":"137","author":"King","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2014.11.002","article-title":"An assessment of MDPV-induced place preference in adult Sprague-Dawley rats","volume":"146","author":"King","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1021\/acschemneuro.5b00006","article-title":"Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats","volume":"6","author":"Kolanos","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib25","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.ajpath.2012.08.013","article-title":"Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a \u03b2-lactam antibiotic during cocaine withdrawal","volume":"181","author":"Kovalevich","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2008.12.003","article-title":"Glutamate and reinstatement","volume":"9","author":"Knackstedt","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","article-title":"Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking","volume":"67","author":"Knackstedt","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib28","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1074\/jbc.M707697200","article-title":"Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes","volume":"283","author":"Lee","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib29","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib32","series-title":"Designer Drugs: the Trends Report 2015","first-page":"8","author":"NMS Labs","year":"2015"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1177\/0269881115598415","article-title":"Concentrations of MDPV in rat striatum correlate with the psychostimulant effect","volume":"29","author":"Novellas","year":"2015","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib34","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1440-1681.2002.03770.x","article-title":"Roles and regulation of glutamate transporters in the central nervous system","volume":"29","author":"O'Shea","year":"2002","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuint.2014.05.016","article-title":"Cocaine-induced neuroadaptations in the dorsal striatum: glutamate dynamics and behavioral sensitization","volume":"75","author":"Parikh","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib36","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.drugalcdep.2011.03.022","article-title":"Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats","volume":"118","author":"Rasmussen","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/FBP.0b013e328337be10","article-title":"\u03b2-Lactam antibiotic inhibits development of morphine physical dependence in rats","volume":"21","author":"Rawls","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib40","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1523\/JNEUROSCI.1746-09.2009","article-title":"Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Sari","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib41","unstructured":"Schindler, C.W., Thorndike, E.B., Goldberg, S.R., Lehner, K.R., Cozzi, N.V., Brandt, S.D., Baumann, M.H., in press. Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats. Psychopharmacology (in press)."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.forsciint.2013.10.002","article-title":"Forensic investigation of K2, Spice, and \u201cbath salt\u201d commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds","volume":"233","author":"Seely","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbr.2011.07.041","article-title":"Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking","volume":"225","author":"Sondheimer","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2013.09.072","article-title":"Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice","volume":"556","author":"Tallarida","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib50","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1523\/JNEUROSCI.1976-12.2012","article-title":"Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training","volume":"32","author":"Trantham-Davidson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib45","series-title":"2014 Global Synthetic Drugs Assessment [Report]","author":"United Nations Office on Drugs and Crime","year":"2014"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2016.04.014_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FBP.0b013e3283473c10","article-title":"Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl\/6 mice","volume":"22","author":"Ward","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.04.014_bib48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T11:08:09Z","timestamp":1617620889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081630154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":50,"alternative-id":["S002839081630154X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}